I
In Vivo | Bydgoszcz, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ertugliflozin
PF-04971729
Orforglipron
Vepugratinib
LY3866288
MK-8835
Pirtobrutinib
MK-8835-059
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 8 total trials
The main purpose of Part 1 of this study is to assess the efficacy and safety of 3 dose levels of Pirtobrutinib in participants with chronic lymphocy...
Enrolling
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib
The GZPS master protocol will support two independent studies, J2A-MC-GZS1 and J2A-MC-GZS2. Each study will see how well and safely orforglipron work...
Enrolling
Urinary Incontinence,Stress
Drug: Placebo
Drug: Orforglipron
The purpose of this study is to test a new medicine, vepugratinib, in comparison with placebo, to see if it is safe and can help people with a bladde...
Begins enrollment this month
Urinary Bladder Neoplasms
Neoplasm Metastasis
Drug: Vepugratinib
Drug: EV
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems